Enanta Pharmaceuticals Inc (NASDAQ:ENTA)
| 54.19 Delayed Data As of 4:00pm ET |  +0.84 / +1.57%Today’s Change | 53.26 Today|||52-Week Range 106.80 | -12.29% Year-to-Date |
Latest ENTA News | Press Releases
No recent news for Enanta Pharmaceuticals Inc.
Today’s Trading
| Previous close | 53.35 |
| Today’s open | 53.65 |
| Day’s range | 53.50 - 54.53 |
| Volume | 127,915 |
| Average volume (3 months) | 202,859 |
| Market cap | $1.1B |
Data as of 4:00pm ET, 01/28/2020
Growth & Valuation
| Earnings growth (last year) | -36.62% |
| Earnings growth (this year) | -139.04% |
| Earnings growth (next 5 years) | -83.30% |
| Revenue growth (last year) | -0.69% |
| P/E ratio | 24.5 |
| Price/Sales | 6.14 |
| Price/Book | 2.34 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| OPKOPKO Health Inc | +0.04 | +2.55% |
| ATNXAthenex Inc | +0.39 | +2.81% |
| PTLAPortola Pharmaceutic... | -0.11 | -0.83% |
| DERMDermira Inc | +0.09 | +0.48% |
Data as of 4:00pm ET, 01/28/2020
Financials
| Next reporting date | February 7, 2020 |
| EPS forecast (this quarter) | $0.58 |
| Annual revenue (last year) | $205.2M |
| Annual profit (last year) | $46.4M |
| Net profit margin | 22.60% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Watertown, Massachusetts |
Forecasts
